Didactic Exam

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/212

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 1:33 AM on 9/1/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

213 Terms

1
New cards

drug monograph

a comprehensive, organized summary of information about a medication designed to help healthcare professionals use the drug safely and effectively

2
New cards

The drug monograph is written by ________ and is approved by _____

manufacturer

FDA

3
New cards

What law helped establish requirements for accurate and informative labeling of products

Fair packaging and Labeling Act (1966)

4
New cards

Code of Federal Regulations (CFR)

the collection of federal regulations/rules

divided into 50 titles representing broad areas subject to federal regulation

5
New cards

Which CFR title contains federal drug regulations?

CFR 21

6
New cards

Generic Name

US Adopted Names Council (USAN) works with manufacturers to establish names

  • similar drug names often have the same stem (lisinopril, fosinopril)


7
New cards

Brand Name

aka trade name: pharmaceutical manufacturer proposes a proprietary name then gets approved approved by FDA

  • may have slight differences in inactive ingredients, but still equivalent active ingredients


8
New cards

Indications

why you would use the drug

9
New cards

difference between labeled indications and off-label indications

labeled indications are specifically what the drug is for while off-label indications are another way the drug can be used (ex: opioid withdrawal with clonidine)

10
New cards

clinical data means it was conducted in ________ while nonclinical data means it was conducted in _____

humans

animals

11
New cards

contraindications

when to NOT use this drug

  • a specific situation where the drug should not be used because the potential risk of harm outweighs any possible therapeutic benefit


12
New cards

absolute contraindication vs relative contraindication

DO NOT USE vs. usually avoid/use cautiously

13
New cards

Warnings and Precautions on a drug

when should I be especially careful?

  • identifies a discrete set of adverse reactions or other potential safety hazards that are serious or are otherwise clinically significant because they have implications for prescribing decisions or for patient management

  • also can show what patient populations are at risk, medical conditions that may increase risk of harm, etc.


14
New cards

Adverse Reactions

unwanted effects that might occur

  • the rxn could be related to the pharmacological action of the drug, and therefore predictable, or it could be unpredictable


15
New cards

What are the FDA approved labeling for patients? (4)

Patient Package Inserts (PPI)

Medication Guides (MGs)

Patient Instructions for Use (IFU)

May 2023 proposed rule - Patient Medication Information (PMI)

16
New cards

Patient Package Inserts (PPI)

tells the patient about their medication

  • they are developed by the manufacturer

  • “What is this drug? Who shouldn’t use it? how do I take it? what are the important risks and side effects?”

  • reqd for oral contraceptives and estrogen-containing products


17
New cards

Medication Guides

specifically focused on info FDA determines patients need to know to use certain medications safely and effectively to prevent serious side effects

  • patient adherence to directions for use is crucial to the drugs effectiveness

  • reqd for REMS


18
New cards

REMS

Risk Evaluation and Mitigation Strategy

  • a drug safety program that the FDA can require for certain medications with SERIOUS safety concerns to help ensure the benefits of the medication outweighs its risks

  • focuses on preventing, monitoring, and/or managing a specific serious risk by informing, educating, and/or reinforcing actions to reduce the frequency and/or severity of the event


19
New cards

Patient Instructions for Use (IFU)

shows the patient how to use the medication

  • for products that have complicated or detailed patient use instructions

  • injection pens, autoinjectors, inhalers, etc. have these

  • can cover preparation, administration, handling, storage, and disposal


20
New cards

May 2023 proposed rule - Patient Medication Information (PMI)

gives every patient the essential info in a similar format

Required for prescription drugs used, dispensed, or

administered on an outpatient basis, as well as for blood and

blood components transfused in an outpatient setting

• When the rule is finalized, the PMI will:

  • Contain essential information that patients need to

know about the prescription drug

  • FDA-approved one-page document: (Indications,

Warnings, Common side-effects, serious side-effects,

directions for use)

  • Standardized in format

  • Written in understandable language

  • Provided for outpatient prescription drugs


21
New cards

Schedule I (Ci)

drugs with no current medical use with high potential for abuse and/or addiction

  • meth, heroin


22
New cards

Schedule II (CII)

drugs with some medically acceptable uses, but with HIGH potential for abuse and/or addiction. These drugs can be obtained through prescription

  • adderall


23
New cards

Schedule III (CIII)

drugs with low to moderate potential for abuse and/or addiction, but less dangerous than CI or CII. These drugs can be obtained through prescription. Generally are not available over the counter

  • testosderone


24
New cards

Schedule IV (CIV)

drugs with viable medical use and low probability of use or misuse

  • xanax


25
New cards

Schedule V (CV)

drugs with low potential for abuse (lower than schedule IV)

  • pregablin (lyrica)


26
New cards

Boxed Warning

meets one of these 3 criteria:

  • An adverse reaction is so serious in proportion to the benefit of the drug that it needs to be considered before prescribing the drug.

  • There is a serious adverse reaction that can be prevented or reduced in frequency or severity by appropriate use of the drug

  • FDA approved the drug with restrictions to ensure safe use


27
New cards

Beers List

a guide of potentially inappropriate medications that older adults (typically 65 and older) should use with caution or avoid

28
New cards

What are the five beers criteria?

  • avoid if you’re over 65 years old and not in a hospice or a palliative

care setting.

  • cavoid among people with certain health conditions.

  • avoid that cause drug interactions when combined with other medications.

  • avoid due to harmful side effects that outweigh the benefits.

  • use at limited doses or avoided due to their effects on kidney function (renal

impairment).

29
New cards

ectomy

removal

30
New cards

oma

tumor

31
New cards

pathy

disease

32
New cards

osis

abnormal condition

33
New cards

genic

producing

34
New cards

graph

recording instrument

35
New cards

stasis

stopping/controlling

36
New cards

qs

quantity sufficient

37
New cards

mcg

microgram

38
New cards

PO

by mouth

39
New cards

IV

intravenous

40
New cards

SC/SQ

subcutaneous

41
New cards

SL

sublingual

42
New cards

PR

per rectum/rectal

43
New cards

PV

per vagina/ vaginal

44
New cards

IM

intramuscular

45
New cards

INH

inhalation

46
New cards

TOP

topical

47
New cards

ung

ointment

48
New cards

crm

cream

49
New cards

gtt

drops

50
New cards

inj

injection

51
New cards

RR

respiratory rate

52
New cards

Hgb

hemoglobin

53
New cards

Hct

hematocrit

54
New cards

WBC

white blood cell

55
New cards

CBC

complete blood count

56
New cards

SCr

serum creatinine

57
New cards

CrCl

Creatine Clearance

58
New cards

eGFR

estimated glomerular filtration rate

59
New cards

INR

International Normalized Ratio

60
New cards

A1C

measures your avg blood sugar levels over the past 2/3 months

61
New cards

NPO

nothing by mouth

62
New cards

QD

daily

63
New cards

QID

four times a day

64
New cards

QOD

every other day

65
New cards

qHS

at bedtime

66
New cards

ac

before meals

67
New cards

pc

after meals

68
New cards

aa

in equal parts or of each

69
New cards

UD

use as directed

70
New cards

what is a sig

will appear right before directions on the prescriptions

  • means write on label


71
New cards

What is Bloom’s Taxonomy?

• Create – Develop a patient-specific plan

• Evaluate – Determine whether therapy is

appropriate

• Analyze – Identify drug-related problems

• Apply – Counsel and educate a patient

• Understand – Explain what a medication

does

• Remember – Know the medication

72
New cards

What is the foundation to think like a pharmacist?

remember and understand - Brand/generic names, spelling, dosage forms, FDA-approved indications, common adverse rxns, contraindications, precautions, and key counseling info

73
New cards

What info do you need to know for each drug regarding drug cards?

● Brand/Generic name (Recognize and correctly spell)

● Therapeutic Drug Class (found on top right card)

● Common Dosage Forms

○ Formulations only, not specific dosage strengths (e.g., tablet, suspension, cream, injectable, powder,

etc.)

● FDA Indications/Dosages

○ For indications, focus on major categories of indications (e.g., pain, treatment of infections,

treatment of hypertension, etc.) *Some drugs may have multiple indications

○ For dosages, focus on highlighted dosing information only (if there is no highlighted dosing

information on the drug card, do not need to know dosing information)

● Monitoring Parameters

● Contraindications/Precautions

○ Focus on information that is all capitalized in bold face

○ Medications that are pregnancy category X

● Adverse Effects

○ Focus on most common adverse effects or ones associated with significant patient harm

● Patient Consultation

○ Focus on major counseling points related to medication administration or patient safety

● REMS/BEERS List

● CII – CV Control Scheduled medications



74
New cards

What is Lab testing used for?

detect disease

guide treatment

monitor treatment response and/or disease progression

75
New cards

When should labs be ordered? (7)

• To discover disease

• Confirm suspected diagnosis

• Differentiate among possible diagnoses

• Determine stage, activity, or severity of disease

• To detect disease recurrence

• To assess the effectiveness of therapy

• To guide the course of therapy

76
New cards

accuracy

extent to which the mean measurement is close to the true value

77
New cards

precision

reproducibility of the assay (ability to produce the same result repeatedly)

78
New cards

specimen

sample used for lab analysis (whole blood, venous blood, urine, sputum, tissue, etc.)

79
New cards

plasma

water acellular portion of blood

80
New cards

serum

liquid that remains after fibrin clot removed from plasma

81
New cards

qualitative test

results are reported as positive or negative without characterization of degree of positivity or negativity

82
New cards

quantitative test

results are reported as an exact numeric measurement and assessed in context of a reference range of values

83
New cards

semiquantitative test

results are reported as either negative or with varying degrees of positivity without quantification

84
New cards

screening vs. diagnostic tests

screening: Individuals WITHOUT signs/symptom of disease, high sensitivity, and requires confirmation with other tests

diagnostic: individuals WITH signs/symptoms of disease and high specificity

85
New cards

sensitivity

ability to identify positive results in patients who have disease (true positive)

86
New cards

specificity

percent of negative results in people without the disease (true negative)

87
New cards

reference range (normal range)

statistically-derived numerical range obtained by testing a sample of healthy individuals

88
New cards

when should lab errors be suspected?

• Inconsistent result with trend in serial results

• Magnitude of error is great

• Result does not coincide with a confirmatory test

• Result is inconsistent with patient’s clinical status

89
New cards

lab erros are usually caused by __________ errors

processing or equipment

90
New cards

lab results must be interpreted in context of…

what is known about the patient

91
New cards

When interpreting Lab Results

-consider baseline results, if available

-compare lab value to reference range

-assess rate of change of lab value

-identify isolated result vs. trend

92
New cards

spurious lab value

false lab value

  • difficult to differentiate spurious result and real lab value

    • must consider patients clinical picture

    • consider possibility of lab error or other interfering factors

  • repeat testing may be needed to rule out actual abnormality


93
New cards

Centralized Lab testing Advantages and Disadvantages

adv:

  • ability to perform variety of tests

  • automation of testing and result reporting

  • higher quality care standards

  • accuracy of results

disadv:

  • costly

  • turn around time may be slower

  • must be done in one location


94
New cards

Point-of-Care testing (POCT) advantages and disadvantages

adv:

  • portability

  • quicker turn around time

  • per test typically higher, but overall cost may be lower (aka the machine may be cheaper, but the test strips could be more expensive)

disadv:

  • misuse of misinterpretation of results

  • documentation errors

  • inappropriate test material disposal

Clinical Lab Improvement Ammendments of 1988

95
New cards

Home Testing Adv and Disadv

Adv;

  • convenient,

  • less costly

  • rapid turn around time

  • privacy

Disadv:

  • misinterpretation of test results

  • delays. in seeking medical advice

  • lack of pre- and post-test counseling/pyschological support


96
New cards

Complete test kits

obtain own sample, tests sample, and reads results

97
New cards

Collection kits

obtain own sample, mails sample to lab, receives result by mail or telephone

98
New cards

What are the three major areas a central lab is divided into?

chemistry profile analyzers

complete blood count instruments

automated microbe identification systems

99
New cards

What is the Basic Metabolic Panel (BMP)?

basic electrolytes plus renal function

100
New cards

Comprehensive Metabolic Panel (CMP)

everything from a BMP plus a few more to assess liver profile